Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Rank Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use First Approval Date Patent Expiration Date [6] [7]; 1: Abilify
Sober Grid is a leader in the digital health marketplace for mental health and Substance Use Disorder. Sober Grid competes with a rival digital health therapy, reSET-O, made for Opioid Use Disorder by Pear Therapeutics. [7] Click Therapeutics and MAP Health Management [8] are also competitors to Sober Grid.
CRSP data by YCharts.. At least two factors have led to CRISPR Therapeutics' poor performance. First, the company isn't profitable. That's pretty normal for a mid-cap biotech, but with rising ...
The existence of prominent digital therapeutics firms, such as Omada Health and Pear Therapeutics, stimulates innovation and competition, hence promoting market expansion. Furthermore, heightened expenditures from both public and private sectors, coupled with advantageous reimbursement policies that promote the adoption of digital solutions ...
Westford, USA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Digital Therapeutics Market size was USD 1035.6 million in 2023 to USD 1805.6 million by 2031, growing at a CAGR of 7.2% in the forecast period (2024-2031).
PTC Therapeutics, Inc.'s (NASDAQ:PTCT): PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery...
Analysts were expecting sales of $90.98 billion and a profit of $10.56 per share for 2025, according to data compiled by LSEG. However, investors said the 25 cent hit from a stronger dollar was ...